Breast disorders are very common in women with about 70% of them finding clinical changes. In 40% of women, fibrocystic changes occur inside the breast which isn’t tumors yet shape, size and structural changes caused by prolonged hormonal stimulation. In about 13% of women lesion and inflammatory processes can be found. 7% of women get fibroadenoma, which is a benign breast tumor. 10% of women get diagnosed with a malignant neoplasm of breast, which is also typically known as breast cancer.
Malignant breast tumors are the second most common cause of death from tumors, right after lung cancer. Out of all the fatal causes, about 20% of these are caused by breast cancer. It is most common with women from their 20s into menopause period.
Recently, researchers have related BRC1 and BRC2 (two genes) with hereditary malignant breast cancer. A whole list of other factors has also been determined, including obesity, early beginning of the menstrual cycle, late birth as well as postponing the delivery. Malignant tumor of the breast can even occur in men but it is an extremely rare occurrence. Statistics show that one out of 9 women will develop a malignant breast cancer at a specific age. Averagely, women in their 50s are most commonly affected with breast cancers. With older women who are obese there is a higher risk, as some scientists believe that food with a lesser percentage of fats and taking well balanced meals can reduce the risk.
A lump or larger mass inside the breast can be felt during self-checkup. This is usually painless and hard mass with irregular edges. The breast may change its size and shape if there is a tumor growing inside, but this usually occurs at a later stage. An excretion out of the nipple can be noticed, which usually a bloody yellowish fluid is looking a lot like regular pus. Nipples can also change in their shape, form and overall feeling when touched.
Choice of therapy and the prognosis itself highly depends on the stage of this malignant tumor, the type of it and other specific characteristics which are individual. Women’s age, weight, status of menopause and overall health condition all have a significant effect on prognosis and treatment methods which will be taken. Momentarily, malignant tumor of the breast is observed as a systematic disease which needs to be treated locally as well as systematically.
Chemotherapy can be used as a systematic therapy with patients who have a treatable malignant tumor of the breasts. Hormonal therapy includes using antiestrogen medications which can be prescribed to individuals who are diagnosed with malignant tumors depending on estrogen levels. If the tests show that cells of the tumor have receptors for estrogen, hormonal therapy may be applied, which is also used to change the way in which hormones help the body battle against foreign cell growth. Same therapy can have an effect on the entire body, possibly preventing metastases from happening.